SCOPUS 정보 검색 플랫폼

Volumn 189, Issue 1, 2013, Pages 210-216

Cost of neuromodulation therapies for overactive bladder: Percutaneous tibial nerve stimulation versus sacral nerve stimulation

(3) Martinson, Melissa a MacDiarmid, Scott c Black, Edward b

a Technomics Research LLC (United States)

b Reimbursement Strategies LLC (United States)

c Alliance Urology Specialists (United States)

Author keywords

costs and cost analysis; implantable neurostimulators; overactive; transcutaneous electric nerve stimulation; urinary bladder; urinary incontinence

Indexed keywords

CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HOSPITAL CARE; HUMAN; INTERMETHOD COMPARISON; MEDICAL FEE; MEDICAL LITERATURE; MEDICARE; NERVE STIMULATION; NEUROMODULATION; OVERACTIVE BLADDER; PERCUTANEOUS TIBIAL NERVE STIMULATION; PRIORITY JOURNAL; REVIEW; SACRAL NERVE STIMULATION; SENSITIVITY ANALYSIS; TREATMENT OUTCOME;

EID: 84870879732 PISSN: 00225347 EISSN: 15273792 Source Type: Journal
DOI: 10.1016/j.juro.2012.08.085 Document Type: Article

Times cited : (48)

References (11)

1
- 0344235173
- Describing bladder storage function: Overactive bladder syndrome and detrusor overactivity
- P. Abrams Describing bladder storage function: overactive bladder syndrome and detrusor overactivity Urology 62 2003 28
- (2003) Urology , vol.62 , pp. 28
- Abrams, P.¹

2
- 0033849074
- Comorbidities associated with overactive bladder
- J.S. Brown, W.F. McGhan, S. Chokroverty Comorbidities associated with overactive bladder Am J Managed Care 6 2000 S574
- (2000) Am J Managed Care , vol.6 , pp. 574
- Brown, J.S.¹ McGhan, W.F.² Chokroverty, S.³

3
- 77649102023
- Economic costs of overactive bladder in the United States
- M.L. Ganz, A.M. Smalarz, T.L. Krupski Economic costs of overactive bladder in the United States Urology 75 2010 526
- (2010) Urology , vol.75 , pp. 526
- Ganz, M.L.¹ Smalarz, A.M.² Krupski, T.L.³

4
- 58849099645
- Discontinuation rates of anticholinergic medications used for the treatment of lower urinary tract symptoms
- M. Gopal, K. Haynes, S.L. Bellamy Discontinuation rates of anticholinergic medications used for the treatment of lower urinary tract symptoms Obstet Gynecol 112 2008 1311
- (2008) Obstet Gynecol , vol.112 , pp. 1311
- Gopal, M.¹ Haynes, K.² Bellamy, S.L.³

5
- 0021021373
- The Markov process in medical prognosis
- J.R. Beck, S.G. Pauker The Markov process in medical prognosis Med Dec Making 3 1983 419
- (1983) Med Dec Making , vol.3 , pp. 419
- Beck, J.R.¹ Pauker, S.G.²

6
- 0027772390
- Markov models in medical decision making: A practical guide
- F.A. Sonnenberg, J.R. Beck Markov models in medical decision making: a practical guide Med Dec Making 13 1993 322
- (1993) Med Dec Making , vol.13 , pp. 322
- Sonnenberg, F.A.¹ Beck, J.R.²

7
- 0030904545
- Primer on medical decision analysis: Part 5 - Working with Markov processes
- D. Naimark, M.D. Krahn, G. Naglie Primer on medical decision analysis: part 5 - working with Markov processes Med Dec Making 17 1997 152
- (1997) Med Dec Making , vol.17 , pp. 152
- Naimark, D.¹ Krahn, M.D.² Naglie, G.³

8
- 0031886073
- An introduction to Markov modeling for economic evaluation
- A. Briggs, M. Schulpher An introduction to Markov modeling for economic evaluation Pharmacoeconomics 13 1998 397
- (1998) Pharmacoeconomics , vol.13 , pp. 397
- Briggs, A.¹ Schulpher, M.²

9
- 84870904523
- Medicare Program: Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2011; Final Rule, November 29, 2010. 2011 MPFS Payment calculated using the 2011 Conversion factor of $33.9764
- 42 CFR Parts 405, 409 et al. Centers for Medicare & Medicaid Services Baltimore
- 42 CFR Parts 405, 409 et al. Medicare Program: Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011; Final Rule, November 29, 2010. 2011 MPFS Payment calculated using the 2011 Conversion factor of $33.9764 CMS Manual System: Pub 100-20 One-Time Notification, Transmittal 833, Change Request 7300. Emergency Update to the CY 2011 Medicare Physician Fee Schedule (MPFS) Database January 7, 2011 Centers for Medicare & Medicaid Services Baltimore
- (2011) CMS Manual System: Pub 100-20 One-Time Notification, Transmittal 833, Change Request 7300. Emergency Update to the CY 2011 Medicare Physician Fee Schedule (MPFS) Database

10
- 71849119859
- Cost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence
- N.Y. Siddiqui, C.L. Amundsen, A.G. Visco Cost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence J Urol 182 2009 2799
- (2009) J Urol , vol.182 , pp. 2799
- Siddiqui, N.Y.¹ Amundsen, C.L.² Visco, A.G.³

11
- 78751645634
- Five-year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overactivity
- P. Padmanabhan, H.M. Scarpero, D.F. Milam Five-year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overactivity World J Urol 29 2011 51
- (2011) World J Urol , vol.29 , pp. 51
- Padmanabhan, P.¹ Scarpero, H.M.² Milam, D.F.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.